This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other trisomies and partial trisomies of the autosomes, not elsewhere classified
Q17_OTHER_TRISOMI_PARTIAL_TRISOMI_AUTOSOMES_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
44 |
4. Check minimum number of eventsNone |
44 |
5. Include endpointsNone |
44 |
6. Filter based on genotype QC (FinnGen only) |
44 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q9
- Name in latin
- Aliae trisomiae totales et partiales autosomatum non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Other trisomies and partial trisomies of the autosomes, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Chromosomal abnormalities, not elsewhere classified
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 701 | 346 | 355 |
| Only index persons | 488 | 255 | 233 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | - | 9.28 | 6.32 |
| Only index persons | 11.76 | 13.51 | 9.83 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 44 | 22 | 22 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 21.70 | 25.37 | 18.04 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
18
80
3.12
3.14
2.8
3.2
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
19
88
3.04
3.08
7.2
5.4
%
91.7
88.8
0.17
19
88
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
15
64
3.04
2.76
2.6
3.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
7
15
5.33
2.72
2.9
2.9
ng/l
227.1
173.7
—
7
15
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
22
120
2.67
2.54
3.5
4.4
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
5
8
6.87
2.43
1.8
5.1
umol/l
2.5
1.8
—
5
8
(3032080) INR in Blood by Coagulation assay
16
77
2.69
2.33
5.2
5.2
inr
1.1
1.1
—
5
21
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
14
4.78
2.23
5.2
2.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
22
127
2.46
2.19
26.9
12.4
mmol/l
1.2
1.2
0.55
22
122
(42870588) Differential panel, method unspecified - Blood
24
145
2.44
2.16
10.6
10.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
6
15
4.45
2.12
51.8
12.1
mmol/l
25.7
24.7
—
6
15
(3023368) Bacteria identified in Blood by Culture
15
73
2.60
2.11
4.4
4.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
9
33
3.16
2.07
9.0
14.3
mmol/l
8.7
6.4
—
9
33
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
21
3.76
2.06
5.6
7.4
%
107.6
88.2
—
7
21
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
27
3.39
2.05
11.8
19.4
mg/l
1.4
1.2
—
8
27
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
17
3.91
1.91
52.3
11.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
17
94
2.32
1.80
4.2
4.8
mmol/l
7.2
8.4
0.56
17
88
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
20
123
2.15
1.61
5.3
3.4
nmol/l
83.7
71.2
0.69
20
112
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
5
15
3.62
1.57
3.0
8.5
%
183.6
203.7
—
5
15
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
21
3.14
1.56
3.0
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
12
60
2.38
1.56
2.0
3.4
mg/l
3.8
2.4
—
7
42
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
53
2.43
1.54
9.4
17.0
mmol/l
26.5
24.9
0.83
11
53
(3007853) Bacteria identified in Skin by Aerobe culture
9
40
2.56
1.51
2.1
1.6
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
5
16
3.38
1.48
1.8
1.3
g/l
68.2
66.0
—
5
16
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
17
3.18
1.40
2.4
2.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
8
35
2.56
1.35
3.4
4.9
u/l
213.6
239.9
—
8
35
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
12
65
2.16
1.29
3.9
2.6
u/l
99.6
128.2
0.53
12
65
(3013826) Glucose [Moles/volume] in Serum or Plasma
25
178
1.94
1.28
21.1
7.0
mmol/l
6.3
6.5
0.28
25
164
(3015377) Calcium [Moles/volume] in Serum or Plasma
16
98
1.99
1.25
4.8
2.7
mmol/l
2.3
2.4
0.33
16
85
(3042936) Bacteria identified in Isolate by Culture
8
39
2.28
1.23
2.0
1.8
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
39
331
2.56
1.22
28.8
13.2
mmol/l
4.0
3.9
0.11
39
323
(3019550) Sodium [Moles/volume] in Serum or Plasma
39
331
2.56
1.22
28.7
13.2
mmol/l
139.3
139.5
0.14
39
322
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
10
52
2.19
1.17
10.2
7.8
kpa
5.2
5.1
—
10
47
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
14
84
1.98
1.15
2.1
1.7
mmol/l
1.6
1.2
0.57
14
72
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
14
86
1.92
1.07
1.6
3.3
u/l
59.3
56.4
0.15
14
79
(3000991) Gas panel - Venous blood
10
55
2.06
1.02
37.6
9.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
15
96
1.85
1.01
1.7
1.5
—
—
—
0
0
(3012544) pH of Venous blood
11
64
1.96
0.97
8.0
9.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
25
189
1.75
0.97
12.8
9.6
%
3.0
3.2
0.11
25
182
(3019069) Monocytes/100 leukocytes in Blood
25
189
1.75
0.97
12.9
9.9
%
8.9
8.3
0.30
25
182
(3013512) EKG study
8
43
2.05
0.94
4.6
3.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
16
107
1.78
0.93
8.6
7.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
6
32
2.01
0.85
1.2
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
25
196
1.64
0.79
12.8
9.4
%
28.4
31.7
0.83
25
190
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
12
77
1.77
0.78
1.5
1.9
pmol/l
123.8
94.2
—
6
41
(36304419) Bacteria [Presence] in Urine
15
103
1.69
0.78
3.1
4.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
24
2.22
0.77
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
12
80
1.69
0.69
6.9
3.3
estimate
0.0
0.0
—
7
30
(3018010) Neutrophils/100 leukocytes in Blood
24
192
1.55
0.66
13.1
9.3
%
55.7
53.8
0.29
24
186
(40761536) Microorganisms panel - Urine sediment
5
30
1.75
0.63
2.4
4.1
—
—
—
0
0
(3002256) Pathology report gross observation
5
30
1.75
0.63
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
22
0.00
0.61
0.0
1.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
60
1.63
0.59
2.2
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
23
186
1.50
0.58
13.7
9.8
%
0.6
0.6
0.10
23
179
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
39
360
1.73
0.52
20.9
11.6
mg/l
23.5
23.3
0.01
30
249
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
12
86
1.54
0.51
4.5
2.6
ng/l
139.0
24.9
—
7
42
(3022313) Gas panel - Capillary blood
7
49
1.51
0.49
10.3
7.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
19
153
1.43
0.46
6.4
3.2
estimate
0.0
0.0
—
6
29
(3021601) Nitrite [Presence] in Urine by Test strip
19
154
1.41
0.44
8.7
4.5
estimate
0.0
0.0
—
7
30
(3002385) Erythrocyte distribution width [Ratio]
36
330
1.50
0.44
30.6
16.5
%
13.5
13.3
0.39
36
324
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
15
0.00
0.42
0.0
4.3
—
37.0
—
0
10
(40768797) Stomach Pathology biopsy report
5
34
1.53
0.42
1.8
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
10
133
0.68
0.41
1.7
1.8
—
—
—
0
0
(1002224) Polysomnography panel
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10
72
1.50
0.41
5.3
5.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
9
70
1.36
0.40
3.1
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
19
157
1.37
0.39
6.6
3.2
estimate
0.0
0.0
—
7
27
(3044889) 12 lead EKG panel
22
187
1.35
0.37
3.8
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
6
43
1.46
0.37
2.3
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
15
120
1.38
0.36
2.0
1.5
g/l
1.9
1.9
—
9
63
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
6
44
1.42
0.36
2.5
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
28
248
1.35
0.35
21.3
9.4
ml/min/173m2
98.3
96.2
0.13
22
194
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
22
251
0.75
0.34
8.1
4.0
mmol/mol
42.5
38.3
0.92
22
238
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14
112
1.37
0.34
6.2
2.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
54
1.35
0.32
2.1
1.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
28
252
1.31
0.29
3.5
3.6
pmol/l
14.2
14.5
0.25
28
231
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
32
344
0.74
0.28
4.0
3.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
9
74
1.27
0.27
5.8
3.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
82
0.69
0.27
2.3
2.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
15
127
1.27
0.24
6.7
3.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
13
0.00
0.21
0.0
1.6
—
1.3
—
0
7
(3018405) Lactate [Moles/volume] in Arterial blood
0
13
0.00
0.21
0.0
2.6
—
1.1
—
0
13
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3020891) Body temperature
0
14
0.00
0.20
0.0
5.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
52
1.18
0.20
1.5
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
10
85
1.23
0.14
6.9
2.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
106
1.18
0.11
1.9
2.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
24
226
1.14
0.09
4.0
3.9
u/l
29.5
35.6
0.64
24
217
(40761511) CBC panel - Blood by Automated count
38
369
1.22
0.08
17.7
9.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
73
0.79
0.08
2.2
2.4
—
—
—
0
0
(3015736) pH of Urine
13
118
1.14
0.08
4.7
2.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
87
1.04
0.07
1.3
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
8
93
0.83
0.07
2.0
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
23
227
1.03
0.00
6.5
4.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
5.1
—
0
7
(3008037) Lactate [Moles/volume] in Venous blood
0
7
0.00
0.00
0.0
1.3
—
1.1
—
0
7
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
17.4
—
0
7
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.6
—
19.3
—
0
7
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
77
0.89
0.00
2.0
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
68
0.86
0.00
1.2
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
147.8
—
0
8
(3037756) Immunofixation for Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.4
—
3.9
—
0
5
(1761868) Lipid panel - Serum or Plasma
9
98
0.90
0.00
3.4
2.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.3
—
5.8
—
0
6
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
6
0.00
0.00
0.0
1.5
—
12.8
—
0
6
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
1.3
—
0
6
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
37
372
0.97
0.00
32.6
14.6
%
38.3
40.8
1.91
28
335
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
5
0.00
0.00
0.0
1.4
—
108.2
—
0
5
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
1.5
—
0
5
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
9
0.00
-0.00
0.0
7.1
—
54.4
—
0
9
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
9
0.00
-0.00
0.0
7.0
—
3.3
—
0
9
Mortality – FinRegistry
↥Association
Association between endpoint Q17_OTHER_TRISOMI_PARTIAL_TRISOMI_AUTOSOMES_NOT_ELSEW_CLASSIFIED and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_OTHER_TRISOMI_PARTIAL_TRISOMI_AUTOSOMES_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_OTHER_TRISOMI_PARTIAL_TRISOMI_AUTOSOMES_NOT_ELSEW_CLASSIFIED – Other trisomies and partial trisomies of the autosomes, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data